Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2018

Aug 03, 2018

SELL
$10.2 - $13.9 $2,131 - $2,905
-209 Closed
0 $0
Q1 2018

May 11, 2018

SELL
$12.65 - $18.85 $78,493 - $116,964
-6,205 Reduced 96.74%
209 $3,000
Q4 2017

Feb 08, 2018

SELL
$17.45 - $25.6 $44,794 - $65,715
-2,567 Reduced 28.58%
6,414 $114,000
Q3 2017

Nov 06, 2017

BUY
$18.9 - $28.2 $169,740 - $253,264
8,981
8,981 $225,000

Others Institutions Holding PRTK

About Paratek Pharmaceuticals, Inc.


  • Ticker PRTK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 54,862,500
  • Description
  • Paratek Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of life-saving therapies for life-threatening diseases or other public health threats for civilian, government, and military use. Its lead product candidates include NUZYRA, a once-daily oral and intravenous broad-spectru...
More about PRTK
Track This Portfolio

Track Sei Investments CO Portfolio

Follow Sei Investments CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sei Investments CO, based on Form 13F filings with the SEC.

News

Stay updated on Sei Investments CO with notifications on news.